Zhaoliang Yu
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Integrating prognosis-related genes with immune-related gene signature for development and validation of a survival stratification model for early-stage colorectal cancer.
Journal: Translational cancer research
Published: December 10, 2024
Raddeanin A Inhibits Colorectal Cancer Growth and Ameliorates Oxaliplatin Resistance Through the WNT/β-Catenin Signaling Pathway.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 25, 2024
KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition.
Journal: Molecular medicine reports
Published: August 09, 2024
Prognostic Impact of Para-Aortic Lymph Node Dissection in Colorectal Cancer Patients Suspected of Para-Aortic Lymph Node Metastasis: A Retrospective Cohort Study.
Journal: Clinical colorectal cancer
Published: August 06, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 10, 2024
Adipose-derived mesenchymal stromal cells alleviate intestinal fibrosis: The role of tumor necrosis factor-stimulated gene 6 protein.
Journal: International immunopharmacology
Published: March 06, 2024
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2024
Last Updated: 09/26/2026